Walmart Inc. will replace AstraZeneca PLC (Nasdaq: AZN) in the Nasdaq-100 Index ®, the Nasdaq-100 Equal Weighted Index, and the Nasdaq-100 Ex-Tech Sector Index. AstraZeneca PLC will also be removed ...

Lucara Diamond Corp. ("Lucara" or the "Company") is pleased to announce a non-brokered private placement (the "Private Placement") of common shares in the capital of Lucara (the "Common Shares") for ...

Assertio Holdings, Inc. ("Assertio" or the "Company") today announced that results of a clinical trial investigating a novel ...

Celebrating Scientific Advancement Amarin applauds the groundbreaking work addressing sHTG and rare genetic disorders such as familial chylomicronemia syndrome (FCS). These advances help drive patient ...

Navient (Nasdaq: NAVI) announced today the following changes in its leadership structure to better align with its business strategy. Steve Hauber, EVP ...

Cellectis (the "Company") (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop ...

BONK Co-Founder and Director Purchase Signals Continued Confidence in Company's "Revenue-to-Treasury" Strategy Heading into 2026 SCOTTSDALE, ARIZONA / ACCESS Newswire / January 9, 2026 / Bonk, Inc. (N ...

Amazon.com, Inc. looks undervalued with strong EPS growth from cloud & e-commerce. Click for this updated look at AMZN stock ...

Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as "Ping An Bio") announced that it has entered into a non-binding memorandum (the "Investment ...

Ping An Biomedical Co., Ltd. (NASDAQ: PASW) (hereinafter referred to as "Ping An Bio") today announced that it has entered into a series of share purchase ...

Press release - No. 2 / 2026 Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy Access to Gefion, Denmar ...